We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

94 hedge funds and large institutions have $153M invested in Applied Genetic Technologies Corporation in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 26

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

4% more funds holding

Funds holding: 9094 (+4)

4% more capital invested

Capital invested by funds: $147M → $153M (+$6.5M)

Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
2.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
44
Reduced
26
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Asset Management One
76
Asset Management One
Japan
$105K
AIG
77
American International Group
New York
$103K +$33.6K +2,157 +42%
Wells Fargo
78
Wells Fargo
California
$76K -$9.98K -640 -11%
PCM
79
Prelude Capital Management
New York
$71K -$31.9K -2,047 -29%
Federated Hermes
80
Federated Hermes
Pennsylvania
$60K +$66.4K +4,257 New
Walleye Trading
81
Walleye Trading
New York
$47K -$28.1K -1,800 -35%
BG
82
BlackRock Group
United Kingdom
$46K
UBS Group
83
UBS Group
Switzerland
$35K +$38.8K +2,490 New
Legal & General Group
84
Legal & General Group
United Kingdom
$32K +$35.6K +2,282 New
BJ
85
BlackRock Japan
Japan
$16K +$998 +64 +6%
ClearBridge Investments
86
ClearBridge Investments
New York
$16K +$9.3K +596 +110%
MA
87
MUFG Americas
New York
$16K +$14K +900 +450%
TRCT
88
Tower Research Capital (TRC)
New York
$12K -$34.7K -2,226 -72%
AIM
89
Advantage Investment Management
Iowa
$9K +$3.74K +240 +60%
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$8K -$228K -14,628 -96%
BNP Paribas Financial Markets
91
BNP Paribas Financial Markets
France
$7.09K +$3.21K +206 +70%
QI
92
QS Investors
New York
$4K
Barclays
93
Barclays
United Kingdom
$3K -$2.12K -136 -39%
MTIP
94
Magee Thomson Investment Partners
California
$1K -$3.4K -218 -83%
RCM
95
RA Capital Management
Massachusetts
-$3.3M -236,059 Closed
VAM
96
Visium Asset Management
New York
-$2.16M -154,751 Closed
Point72 Asset Management
97
Point72 Asset Management
Connecticut
-$1.07M -76,659 Closed
TI
98
Trexquant Investment
Connecticut
-$586K -41,882 Closed
DTL
99
Dynamic Technology Lab
Singapore
-$428K -30,584 Closed
AL
100
Airain Ltd
Guernsey
-$240K -17,160 Closed

AGTC Hedge Fund Activity: Q2 2016 in Review

94 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2016, worth a combined $153M — up 4.4% from $147M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AGTC positions and 8 closed out — a net gain of 5 holders — while 44 added to existing stakes and 26 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $3.16M. The largest seller was RA Capital Management, exiting entirely with an estimated $3.3M sold.

  • 94 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2016, up from 90 in Q1 2016.
  • Funds reported $153M of Applied Genetic Technologies Corporation stock for Q2 2016, up 4.4% quarter-over-quarter.
  • 13 funds opened new Applied Genetic Technologies Corporation positions in Q2 2016 and 8 closed out, a net change of +5 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2016 was Acadian Asset Management, an estimated $3.16M added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2016 was RA Capital Management, an estimated $3.3M sold.

Based on aggregated 13F filings for Q2 2016.